InvestorsHub Logo
icon url

eicoman

06/21/12 7:54 AM

#4438 RE: Klubhead #4437

well said Klubhead, when I spoke to Damaj yesterday he really emphasized that point, biotechs today grow thru acquisition and get to the point to be acquired, also no other product exists that matches NexAct's ability to deliver drugs without irritation to the skin. These guys are making a lot of smart moves towards growth. My plan is top keep accumulating over the next 2-3 years.
icon url

tradero

06/21/12 9:16 AM

#4440 RE: Klubhead #4437

I also agree... But the only thing I didn't like was they said Vitaros will not be launched in France (rest of Europe) till 2013 2q ...

Just a potential patient complaint :-)